$DXCM
DEXCOM INC Stock $dxcm

$dxcm Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000109355719000119 Filed on May 01, 2019

Income Statement

Concept	2019 Q1	2018 Q1
Revenue	$280.5M	$184.4M
YoY Change	52.11%	29.59%
Cost Of Revenue	$111.7M	$65.50M
YoY Change	70.53%	35.89%
Gross Profit	$168.8M	$118.9M
YoY Change	41.97%	26.35%
Gross Profit Margin	60.18%	64.48%
Selling, General & Admin	$124.2M	$104.8M
YoY Change	18.51%	21.3%
% of Gross Profit	73.58%	88.14%
Research & Development	$59.00M	$44.80M
YoY Change	31.7%	-6.86%
% of Gross Profit	34.95%	37.68%
Depreciation & Amortization	$9.900M	$6.000M
YoY Change	65.0%	62.16%
% of Gross Profit	5.86%	5.05%
Operating Expenses	$183.2M	$149.6M
YoY Change	22.46%	11.23%
Operating Profit	-$14.40M	-$30.70M
YoY Change	-53.09%	-24.01%
Interest Expense	$14.90M	$4.800M
YoY Change	210.42%	860.0%
% of Operating Profit
Other Income/Expense, Net	$6.900M	$2.600M
YoY Change	165.38%	550.0%
Pretax Income	-$26.60M	-$24.00M
YoY Change	10.83%	-40.45%
Income Tax	$300.0K	$200.0K
% Of Pretax Income
Net Earnings	-$26.90M	-$24.20M
YoY Change	11.16%	-41.97%
Net Earnings / Revenue	-9.59%	-13.12%
Basic Earnings Per Share	-$0.30	-$0.28
Diluted Earnings Per Share	-$0.30	-$0.28
COMMON SHARES
Basic Shares Outstanding	90.30M shares	87.00M shares
Diluted Shares Outstanding	90.30M shares

Balance Sheet

Concept	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.358B	$521.5M
YoY Change	160.4%	187.96%
Cash & Equivalents	$1.285B	$420.4M
Short-Term Investments	$72.90M	$101.1M
Other Short-Term Assets	$27.00M	$19.90M
YoY Change	35.68%	17.06%
Inventory	$101.1M	$51.60M
Prepaid Expenses
Receivables	$204.7M	$123.9M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.691B	$729.3M
YoY Change	131.84%	120.67%
LONG-TERM ASSETS
Property, Plant & Equipment	$221.4M	$152.4M
YoY Change	45.28%	23.5%
Goodwill	$18.60M	$12.30M
YoY Change	51.22%	7.89%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$15.50M	$2.800M
YoY Change	453.57%	47.37%
Total Long-Term Assets	$283.2M	$167.5M
YoY Change	69.07%	22.53%
TOTAL ASSETS
Total Short-Term Assets	$1.691B	$729.3M
Total Long-Term Assets	$283.2M	$167.5M
Total Assets	$1.974B	$896.8M
YoY Change	120.12%	91.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$90.30M	$38.90M
YoY Change	132.13%	117.32%
Accrued Expenses	$140.8M	$83.30M
YoY Change	69.03%	7.35%
Deferred Revenue	$2.700M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$500.0K
YoY Change
Total Short-Term Liabilities	$235.4M	$125.1M
YoY Change	88.17%	-27.14%
LONG-TERM LIABILITIES
Long-Term Debt	$1.038B	$338.7M
YoY Change	206.35%	4955.22%
Other Long-Term Liabilities	$18.10M	$18.70M
YoY Change	-3.21%	5.65%
Total Long-Term Liabilities	$18.10M	$18.70M
YoY Change	-3.21%	5.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$235.4M	$125.1M
Total Long-Term Liabilities	$18.10M	$18.70M
Total Liabilities	$1.305B	$475.1M
YoY Change	174.76%	150.84%
SHAREHOLDERS EQUITY
Retained Earnings	-$823.7M	-$696.0M
YoY Change	18.35%	4.93%
Common Stock	$1.591B	$1.123B
YoY Change	41.7%	19.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$100.0M
YoY Change
Treasury Stock Shares	800.0K shares
Shareholders Equity	$668.6M	$421.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.974B	$896.8M
YoY Change	120.12%	91.95%

Cashflow Statement

Concept	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	-$26.90M	-$24.20M
YoY Change	11.16%	-41.97%
Depreciation, Depletion And Amortization	$9.900M	$6.000M
YoY Change	65.0%	62.16%
Cash From Operating Activities	$11.80M	-$8.700M
YoY Change	-235.63%	-3000.0%
INVESTING ACTIVITIES
Capital Expenditures	$39.30M	$15.30M
YoY Change	156.86%	-33.19%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$100.0K
YoY Change	-100.0%	-106.67%
Cash From Investing Activities	$131.3M	-$15.40M
YoY Change	-952.6%	-28.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$5.000M	$4.200M
YoY Change	19.05%	-20.75%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$4.900M	$4.200M
YoY Change	16.67%	-94.77%
NET CHANGE
Cash From Operating Activities	$11.80M	-$8.700M
Cash From Investing Activities	$131.3M	-$15.40M
Cash From Financing Activities	$4.900M	$4.200M
Net Change In Cash	$148.6M	-$20.80M
YoY Change	-814.42%	-135.25%
FREE CASH FLOW
Cash From Operating Activities	$11.80M	-$8.700M
Capital Expenditures	$39.30M	$15.30M
Free Cash Flow	-$27.50M	-$24.00M
YoY Change	14.58%	6.19%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001093557
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	91050405	shares
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	DEXCOM INC
CY2019Q1	dxcm	Amortization Periodfor Incentive Compensation Costs AmortizationPeriodforIncentiveCompensationCosts	P1Y
CY2019Q1	dxcm	Concentration Risk Percentageof Accounts Receivableattributabletocustomer ConcentrationRiskPercentageofAccountsReceivableattributabletocustomer	0.1
CY2018Q4	dxcm	Debt Securities Available For Saleand Equity Securities DebtSecuritiesAvailableForSaleandEquitySecurities	248600000	USD
CY2019Q1	dxcm	Debt Securities Available For Saleand Equity Securities DebtSecuritiesAvailableForSaleandEquitySecurities	72900000	USD
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2019Q1	dei	Trading Symbol TradingSymbol	DXCM
CY2018Q4	dxcm	Accrued Tax Audit And Legal Fees AccruedTaxAuditAndLegalFees	11700000	USD
CY2019Q1	dxcm	Accrued Tax Audit And Legal Fees AccruedTaxAuditAndLegalFees	12300000	USD
CY2019Q1	dxcm	Customer Concentration Number Of Customers CustomerConcentrationNumberOfCustomers	2	customer
CY2018	dxcm	Debt Securities Available For Saleand Equity Securities Unrealized Gain DebtSecuritiesAvailableForSaleandEquitySecuritiesUnrealizedGain	36000000	USD
CY2018	dxcm	Debt Securities Available For Saleand Equity Securities Unrealized Loss DebtSecuritiesAvailableForSaleandEquitySecuritiesUnrealizedLoss	100000	USD
CY2018Q4	dxcm	Debt Securities Availableforsaleand Equity Securities Amortized Cost DebtSecuritiesAvailableforsaleandEquitySecuritiesAmortizedCost	212700000	USD
CY2018Q1	dxcm	Fair Value Assets Level3 Transfers Amount FairValueAssetsLevel3TransfersAmount	0	USD
CY2019Q1	dxcm	Fair Value Assets Level3 Transfers Amount FairValueAssetsLevel3TransfersAmount	0	USD
CY2019Q1	dxcm	Finance Lease Short Term Leases Payments Due FinanceLeaseShortTermLeasesPaymentsDue	0	USD
CY2019Q1	dxcm	Finance Leases Liability Less Payments Due On Short Term Leases Not Recorded As A Liability FinanceLeasesLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability	15700000	USD
CY2018Q4	dxcm	Financing Lease Obligation FinancingLeaseObligation	7300000	USD
CY2019Q1	dxcm	Financing Lease Obligation FinancingLeaseObligation	15200000	USD
CY2019Q1	dxcm	Lessee Operating Leases Short Term Lease Payments Due LesseeOperatingLeasesShortTermLeasePaymentsDue	-900000	USD
CY2018Q3	dxcm	Loss Contingencies Patents Allegedly Infringed Numberofinterpartesreviewrequested LossContingenciesPatentsAllegedlyInfringedNumberofinterpartesreviewrequested	2	Petition
CY2019Q1	dxcm	Operating Lease Liability Less Payments Due On Short Term Leases Not Recorded As A Liability OperatingLeaseLiabilityLessPaymentsDueOnShortTermLeasesNotRecordedAsALiability	41800000	USD
CY2018Q4	dxcm	Pharmacy Rebates PharmacyRebates	36100000	USD
CY2019Q1	dxcm	Pharmacy Rebates PharmacyRebates	40900000	USD
CY2018Q1	dxcm	Revenue Percentage RevenuePercentage	1
CY2019Q1	dxcm	Revenue Percentage RevenuePercentage	1
CY2019Q1	dxcm	Revenue Recognition Sales Returns Coverage Period RevenueRecognitionSalesReturnsCoveragePeriod	P30D
CY2019Q1	dxcm	Rightof Use Asset Obtainedin Exchangefor Lease Liabilities RightofUseAssetObtainedinExchangeforLeaseLiabilities	45200000	USD
CY2018Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	147100000	USD
CY2019Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	169100000	USD
CY2018Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	75500000	USD
CY2019Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	90300000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	226700000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	204700000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	79800000	USD
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	88400000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1500000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1600000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1560600000	USD
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1590600000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24600000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25000000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24600000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25000000	USD
CY2018Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3700000	USD
CY2019Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	12200000	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7500000	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16700000	shares
CY2018Q4	us-gaap	Assets Assets	1916000000	USD
CY2019Q1	us-gaap	Assets Assets	1974000000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	1699500000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	1690800000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	100000	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	210700000	USD
CY2019Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	72900000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	210600000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	210600000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	72900000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	420400000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1137000000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1285100000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	441500000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	420700000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1137100000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1285700000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-20800000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	148600000	USD
CY2018Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	266000000	USD
CY2019Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	359500000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	91100000	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	92100000	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	90000000	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	91000000	shares
CY2018Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	100000	USD
CY2019Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	100000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26500000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26800000	USD
CY2019Q1	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.1
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2900000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2700000	USD
CY2018Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1500000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2400000	USD
CY2018Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1010300000	USD
CY2019Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1022400000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	65500000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	111700000	USD
CY2019Q1	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2018Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	7400000	USD
CY2019Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-4200000	USD
CY2018Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	9400000	USD
CY2019Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6000000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9900000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.30
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-900000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	600000	USD
CY2019Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.01
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	72400000	USD
CY2019Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	51300000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	188300000	USD
CY2018Q1	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	7400000	USD
CY2019Q1	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-4200000	USD
CY2018Q1	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2019Q1	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0	USD
CY2019Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	200000	USD
CY2019Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	200000	USD
CY2019Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	15700000	USD
CY2019Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	15900000	USD
CY2019Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	500000	USD
CY2019Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	15200000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	21800000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	15400000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	1400000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	1400000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1300000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	1300000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	1000000	USD
CY2019Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	6100000	USD
CY2019Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	100000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	15300000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	300000	USD
CY2019Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.050
CY2019Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P14Y
CY2018Q4	us-gaap	Goodwill Goodwill	18700000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	18600000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	118900000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	168800000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24000000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-26600000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2200000	USD
CY2019Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-21100000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	25500000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10700000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-21500000	USD
CY2018Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-14400000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6400000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	30400000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	100000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-3000000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2700000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5400000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	4800000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	14900000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	28700000	USD
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	38400000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	70700000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	101100000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	30800000	USD
CY2019Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	52700000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	11200000	USD
CY2019Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10000000	USD
CY2018Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	4100000	USD
CY2019Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	6900000	USD
CY2019Q1	us-gaap	Lease Cost LeaseCost	5100000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	46300000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1000000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1600000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3700000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	14500000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	14200000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	11300000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3600000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	1252700000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	1305400000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1916000000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1974000000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	222400000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	235400000	USD
CY2019Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	195600000	USD
CY2019Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2019Q1	us-gaap	Litigation Reserve LitigationReserve	0	USD
CY2019Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4200000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4900000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15400000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	131300000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8700000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11800000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-24200000	USD
CY2019Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	10100000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-26900000	USD
CY2019Q1	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification	2100000	USD
CY2018Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	4300000	USD
CY2019Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	149600000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	183200000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-30700000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-14400000	USD
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	2500000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	42700000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	40400000	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12300000	USD
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	29500000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	4600000	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	27700000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26700000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.050
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M2D
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	17000000	USD
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18500000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14700000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15500000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2300000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2300000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	100000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2300000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	100000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	100000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	20000000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18100000	USD
CY2018Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	900000	USD
CY2019Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-300000	USD
CY2018Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	3300000	USD
CY2019Q1	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	2900000	USD
CY2018Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	32000000	USD
CY2019Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	50700000	USD
CY2018Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1000000	USD
CY2019Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1200000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15300000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39300000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2019Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16500000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27000000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4200000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5000000	USD
CY2018Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2019Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-100000	USD
CY2018Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	32900000	USD
CY2019Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	222500000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	262900000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	309800000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	183100000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	221400000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44800000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	59000000	USD
CY2018Q1	us-gaap	Restricted Cash RestrictedCash	300000	USD
CY2019Q1	us-gaap	Restricted Cash RestrictedCash	600000	USD
CY2019Q1	us-gaap	Restructuring Charges RestructuringCharges	9000000	USD
CY2018Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2019Q1	us-gaap	Restructuring Reserve RestructuringReserve	1100000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-798900000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-823700000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	184400000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	280500000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	15300000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	29900000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	104800000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	124200000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	24600000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	25000000	USD
CY2019Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1300000	USD
CY2018Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	6800000	USD
CY2019Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	6000000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	100000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	200000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4100000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4800000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	419400000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	421700000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	663300000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	668600000	USD
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	800000	shares
CY2019Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	800000	shares
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	100000000	USD
CY2019Q1	us-gaap	Treasury Stock Value TreasuryStockValue	100000000	USD
CY2018Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	5100000	USD
CY2019Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	4700000	USD
CY2019Q1	us-gaap	Variable Lease Cost VariableLeaseCost	800000	USD
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	87300000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	90300000	shares
CY2019Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term investment securities, and accounts receivable. We limit our exposure to credit loss by placing our cash and investments with high credit quality financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</font></div></div>
CY2019Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</font></div></div>
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with </font><font style="font-family:inherit;font-size:10pt;">GAAP</font><font style="font-family:inherit;font-size:10pt;"> requires us to make estimates and assumptions that affect the amounts reported in our financial statements and the disclosures made in the accompanying notes. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates. </font></div></div>

Files In Submission

Name	View Source	Status
0001093557-19-000119-index-headers.html	Edgar Link	pending
0001093557-19-000119-index.html	Edgar Link	pending
0001093557-19-000119.txt	Edgar Link	pending
0001093557-19-000119-xbrl.zip	Edgar Link	pending
dxcm-20190331.xml	Edgar Link	completed
dxcm-20190331.xsd	Edgar Link	pending
dxcm-20190331_cal.xml	Edgar Link	unprocessable
dxcm-20190331_def.xml	Edgar Link	unprocessable
dxcm-20190331_lab.xml	Edgar Link	unprocessable
dxcm-20190331_pre.xml	Edgar Link	unprocessable
dxcm-2019x10qasof33119.htm	Edgar Link	pending
dxcm3312019exhibit3101.htm	Edgar Link	pending
dxcm3312019exhibit3102.htm	Edgar Link	pending
dxcm3312019exhibit3201.htm	Edgar Link	pending
dxcm3312019exhibit3202.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DXCM
DEXCOM INC Stock $dxcm

2019 Q1 Form 10-Q Financial Statement

#000109355719000119 Filed on May 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DXCM DEXCOM INC Stock $dxcm

2019 Q1 Form 10-Q Financial Statement

#000109355719000119 Filed on May 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DXCM
DEXCOM INC Stock $dxcm